Ovarian cancer metastasis: Looking beyond the surface.
Bayraktar E, Chen S, Corvigno S, Liu J, Sood AK.
Cancer Cell. 2024 Oct 14;42(10):1631-1636. doi: 10.1016/j.ccell.2024.08.016. Epub 2024 Sep 12.
HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Buza N.
Int J Gynecol Pathol. 2021 Jan;40(1):17-23. doi: 10.1097/PGP.0000000000000711.
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C.
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.
Vyhlídalová Kotrbová A, Gömöryová K, Mikulová A, Plešingerová H, Sladeček S, Kravec M, Hrachovinová Š, Potěšil D, Dunsmore G, Blériot C, Bied M, Kotouček J, Bednaříková M, Hausnerová J, Minář L, Crha I, Felsinger M, Zdráhal Z, Ginhoux F, Weinberger V, Bryja V, Pospíchalová V.
J Extracell Vesicles. 2024 Mar;13(3):e12420. doi: 10.1002/jev2.12420.
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
Voutsadakis IA.
Int J Gynecol Cancer. 2020 Oct;30(10):1619-1626. doi: 10.1136/ijgc-2019-000832. Epub 2019 Nov 27.
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study.
Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J; Consortium STIC focusgroup; Hermens RPMG, Steenbeek MP.
BJOG. 2024 Dec;131(13):1851-1861. doi: 10.1111/1471-0528.17919. Epub 2024 Jul 25.
Uterine papillary serous carcinoma: what have we learned over the past quarter century?
Goff BA.
Gynecol Oncol. 2005 Sep;98(3):341-3. doi: 10.1016/j.ygyno.2005.07.006.
Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis.
Travaglino A, Santoro A, Arciuolo D, Scaglione G, Raffone A, Piermattei A, Onori ME, Minucci A, Pedone Anchora L, Fanfani F, Zannoni GF.
Pathologica. 2024 Jun;116(3):176-179. doi: 10.32074/1591-951X-974.
Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
Angarita AM, Cholakian D, Fader AN.
Expert Rev Anticancer Ther. 2015;15(8):893-9. doi: 10.1586/14737140.2015.1052411. Epub 2015 Jun 3.
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.
Toboni M, Kurnit K, Erickson B, Powell M, Secord AA, Fader AN.
Int J Gynecol Cancer. 2025 Mar;35(3):101672. doi: 10.1016/j.ijgc.2025.101672. Epub 2025 Jan 30.
